As both CNTNAP2 and PTPRD analyses predated the updated WHO diffuse glioma classification, we analyzed these further in the TCGA cohort with updated tumor classification based on IDH mutation and 1p19q co-deletion. The gene discussed is IDH1; the disease is neoplasm.